TWF1 and Tremor: On the other hand, if a given drug passes both Test 1 and Test 2, so that it suppresses tremor in doses that do not cause psychomotor impairment, an effect abolished in α6 KO mice, then such a finding will support the hypothesis that an α6-GABAA receptor modulating drug can suppress tremor in tolerated doses.